<!DOCTYPE html>
<html class="client-nojs" lang="en" dir="ltr">
<head>
<meta charset="UTF-8"/>
<title>Traumatic Glaucoma - EyeWiki</title>
<script>document.documentElement.className="client-js";RLCONF={"wgBreakFrames":!1,"wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"mdy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgRequestId":"ZAVPGvUd8R6s8usrqgLi6wAAAAg","wgCSPNonce":!1,"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":!1,"wgNamespaceNumber":0,"wgPageName":"Traumatic_Glaucoma","wgTitle":"Traumatic Glaucoma","wgCurRevisionId":89296,"wgRevisionId":89296,"wgArticleId":9619,"wgIsArticle":!0,"wgIsRedirect":!1,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["Articles","Glaucoma","Ocular Trauma"],"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgRelevantPageName":"Traumatic_Glaucoma","wgRelevantArticleId":9619,"wgIsProbablyEditable":!1,"wgRelevantPageIsProbablyEditable":!1,"wgRestrictionEdit":[],"wgRestrictionMove":[],"sdgDownArrowImage":
"/w/extensions/SemanticDrilldown/skins/down-arrow.png","sdgRightArrowImage":"/w/extensions/SemanticDrilldown/skins/right-arrow.png","wgCiteDrawerEnableDesktop":!1,"wgCiteDrawerEnableMobile":!0,"wgCiteDrawerTheme":"dark","wgPageFormsTargetName":null,"wgPageFormsAutocompleteValues":[],"wgPageFormsAutocompleteOnAllChars":!1,"wgPageFormsFieldProperties":[],"wgPageFormsCargoFields":[],"wgPageFormsDependentFields":[],"wgPageFormsCalendarValues":[],"wgPageFormsCalendarParams":[],"wgPageFormsCalendarHTML":null,"wgPageFormsGridValues":[],"wgPageFormsGridParams":[],"wgPageFormsContLangYes":null,"wgPageFormsContLangNo":null,"wgPageFormsContLangMonths":[],"wgPageFormsHeightForMinimizingInstances":800,"wgPageFormsShowOnSelect":[],"wgPageFormsScriptPath":"/w/extensions/PageForms","edgValues":[],"wgPageFormsEDSettings":null,"wgAmericanDates":!0,"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","pageVariantFallbacks":"en"},"srfFilteredConfig":null,
"wgEditSubmitButtonLabelPublish":!1};RLSTATE={"site.styles":"ready","noscript":"ready","user.styles":"ready","user":"ready","user.options":"loading","ext.cite.styles":"ready","mediawiki.ui.button":"ready","skins.chameleon":"ready","zzz.ext.bootstrap.styles":"ready","mediawiki.toc.styles":"ready","ext.CookieWarning.styles":"ready","oojs-ui-core.styles":"ready","oojs-ui.styles.indicators":"ready","mediawiki.widgets.styles":"ready","oojs-ui-core.icons":"ready","ext.visualEditor.desktopArticleTarget.noscript":"ready","ext.srf.styles":"ready","ext.smw.style":"ready","ext.smw.tooltip.styles":"ready"};RLPAGEMODULES=["ext.smw.style","ext.smw.tooltips","ext.cite.ux-enhancements","smw.entityexaminer","site","mediawiki.page.startup","mediawiki.page.ready","mediawiki.toc","ext.citedrawer.main","ext.CookieWarning","ext.visualEditor.desktopArticleTarget.init","ext.visualEditor.targetLoader","ext.eyeWiki","ext.eyeWiki.slideshow","sentry.init","ext.bootstrap.scripts"];</script>
<script>(RLQ=window.RLQ||[]).push(function(){mw.loader.implement("user.options@1hzgi",function($,jQuery,require,module){/*@nomin*/mw.user.tokens.set({"patrolToken":"+\\","watchToken":"+\\","csrfToken":"+\\"});
});});</script>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.CookieWarning.styles%7Cext.cite.styles%7Cext.visualEditor.desktopArticleTarget.noscript%7Cmediawiki.toc.styles%7Cmediawiki.ui.button%7Cmediawiki.widgets.styles%7Coojs-ui-core.icons%2Cstyles%7Coojs-ui.styles.indicators%7Cskins.chameleon%7Czzz.ext.bootstrap.styles&amp;only=styles&amp;skin=chameleon"/>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.smw.style%7Cext.smw.tooltip.styles&amp;only=styles&amp;skin=chameleon"/>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.srf.styles&amp;only=styles&amp;skin=chameleon"/>
<script async="" src="/w/load.php?lang=en&amp;modules=startup&amp;only=scripts&amp;raw=1&amp;skin=chameleon"></script>
<style>#mw-indicator-mw-helplink {display:none;}</style>
<meta name="ResourceLoaderDynamicStyles" content=""/>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=site.styles&amp;only=styles&amp;skin=chameleon"/>
<meta name="generator" content="MediaWiki 1.35.8"/>
<meta name="description" content="Traumatic glaucoma is a type of secondary  glaucoma that develops following blunt or penetrating ocular trauma. This subtype of glaucoma usually entails several mechanisms that interplay to produce increased intraocular pressure (IOP)  and it is important to consider all the pathophysiological mechanisms leading to increased IOP as they influence management of patients. Furthermore, it is important to recognize traumatic glaucoma given the significant number of patients affected every year as discussed in the incidence and prevalence sections below."/>
<meta name="date" content="2023-02-02"/>
<meta name="WT.seg_1" content="0"/>
<meta name="google-site-verification" content="mtQvMIGqpWB4oyYM5mux15MHU-3qWI0bWtyRa2b5rlk"/>
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"/>
<link rel="alternate" type="application/rdf+xml" title="Traumatic Glaucoma" href="/w/index.php?title=Special:ExportRDF/Traumatic_Glaucoma&amp;xmlmime=rdf"/>
<link rel="shortcut icon" href="/w/extensions/EyeWiki/favicons/favicon.ico"/>
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="EyeWiki (en)"/>
<link rel="EditURI" type="application/rsd+xml" href="https://eyewiki.org/w/api.php?action=rsd"/>
<link rel="preconnect" href="https://fonts.gstatic.com">
<link href="https://fonts.googleapis.com/css2?family=Lato:ital,wght@0,400;0,700;1,400&display=swap" rel="stylesheet">
<!-- Favicons MEYE-108 -->
<link rel="apple-touch-icon" sizes="120x120" href="/w/extensions/EyeWiki/favicons/apple-touch-icon.png">
<link rel="icon" type="image/png" sizes="32x32" href="/w/extensions/EyeWiki/favicons/favicon-32x32.png">
<link rel="icon" type="image/png" sizes="16x16" href="/w/extensions/EyeWiki/favicons/favicon-16x16.png">
<link rel="manifest" href="/w/extensions/EyeWiki/favicons/site.webmanifest">
<link rel="mask-icon" href="/w/extensions/EyeWiki/favicons/safari-pinned-tab.svg" color="#603cba">
<link rel="shortcut icon" href="/w/extensions/EyeWiki/favicons/favicon.ico">
<meta name="msapplication-TileColor" content="#603cba">
<meta name="msapplication-config" content="/w/extensions/EyeWiki/favicons/browserconfig.xml">
<meta name="theme-color" content="#ffffff">
<script> window.interdeal = { "sitekey": "81c701489fb8bb4ab90ca1cb0931f9c5", "Position": "Left", "Menulang": "EN", "domains": { "js": "https://cdn.equalweb.com/", "acc": "https://access.equalweb.com/" }, "btnStyle": { "vPosition": [ "80%", null ], "scale": [ "0.8", "0.8" ], "color": { "main": "#1876c9" }, "icon": { "type": 1, "outline": false } } }; (function(doc, head, body){ var coreCall = doc.createElement('script'); coreCall.src = 'https://cdn.equalweb.com/core/4.3.8/accessibility.js'; coreCall.defer = true; coreCall.integrity = 'sha512-u6i35wNTfRZXp0KDwSb3TntaIKI2ItCt/H/KcYIsBeVbaVMerEQLBnU5/ztfBg9aSW1gg7AN4CqCu9a455jkUg=='; coreCall.crossOrigin = 'anonymous'; coreCall.setAttribute('data-cfasync', true ); body? body.appendChild(coreCall) : head.appendChild(coreCall); })(document, document.head, document.body); </script>
<!--[if lt IE 9]><script src="/w/resources/lib/html5shiv/html5shiv.js"></script><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject page-Traumatic_Glaucoma rootpage-Traumatic_Glaucoma layout-standard skin-chameleon action-view">
	<div class="flex-fill container">
		<div class="row">
			<div class="flex-grow-0 col-12 col-cmln-6 d-flex flex-column flex-md-row w-md-100 justify-content-start align-items-center col">
					<div class="float-left mr-3 mb-2"><a href="//aao.org"><img id="aao-logo" src="/w/extensions/EyeWiki/skins/chameleon/AAO_Logo.png"></a></div>
                		
				<!-- logo and main page link -->
				<div id="p-logo" class="p-logo" role="banner">
					<a href="/Main_Page" title="Visit the main page"><img src="/w/extensions/EyeWiki/skins/chameleon/EyeWiki_Logo.png" alt="EyeWiki"/></a>
				</div>
			</div>
			<div class="ml-auto col-12 col-cmln col">
				<div class="row">
					<div class="col">
						<!-- personal tools -->
						<div class="p-personal pull-right" id="p-personal" >
							<ul class="p-personal-tools" >
								<li id="pt-createaccount"><a href="/w/index.php?title=Special:CreateAccount&amp;returnto=Traumatic+Glaucoma" title="You are encouraged to create an account and log in; however, it is not mandatory" class="pt-createaccount">Create account</a></li>
								<li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Traumatic+Glaucoma" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o" class="pt-login">Log in</a></li>
							</ul>
						</div>

					</div>
				</div>
				<div class="row">
					<div class="col">
						<!-- search form -->
						<div  id="p-search" class="p-search pull-right" role="search"  >
							<form  id="searchform" class="mw-search" action="/w/index.php" >
								<input type="hidden" name="title" value=" Special:Search" />
								<div class="input-group">
									<input name="search" placeholder="Search EyeWiki" title="Search EyeWiki [f]" accesskey="f" id="searchInput" class="form-control"/>
									<div class="input-group-append">
										<button value="Go" id="searchGoButton" name="go" type="submit" class="search-btn searchGoButton" aria-label="Go to page" title="Go to a page with this exact name if it exists"></button>
									</div>
								</div>
							</form>
						</div>
					</div>
				</div>
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- navigation bar -->
				<nav class="p-navbar collapsible mb-3 mt-2 p-1 mt-cmln-0" role="navigation" id="mw-navigation">
					<button type="button" class="navbar-toggler" data-toggle="collapse" data-target="#hbpxgz0x6p"></button>
					<div class="collapse navbar-collapse hbpxgz0x6p" id="hbpxgz0x6p">
						<div class="navbar-nav"><div class="nav-item"><a class="nav-link fas fa-home"  href="/Main_Page">Main Page</a></div><div class="nav-item"><a class="nav-link fas fa-book"  href="/Category:Articles">Articles</a></div><div class="nav-item"><a class="nav-link fas fa-play"  href="/Help:Getting_Started">Getting Started</a></div><div class="nav-item"><a class="nav-link fas fa-question"  href="/Help:Contents">Help</a></div><div class="nav-item"><a class="nav-link fas fa-backward"  href="/Special:RecentChanges">Recent changes</a></div><div class="nav-item"><a class="nav-link fas fa-door-open"  href="#">My Portal</a></div>
						</div>
					</div>
				</nav>
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- Content navigation -->
				<div class="mb-3 pagetools p-contentnavigation" id="p-contentnavigation">
					<!-- namespaces -->
					<div id="p-namespaces" class="p-namespaces">
						<div class="tab-group">
							<div id="ca-nstab-main" class="selected"><a href="/Traumatic_Glaucoma" title="View the content page [c]" accesskey="c" class="selected ca-nstab-main">Page</a></div>
							<div id="ca-talk" class="new"><a href="/w/index.php?title=Talk:Traumatic_Glaucoma&amp;action=edit&amp;redlink=1" rel="discussion" title="Discussion about the content page (page does not exist) [t]" accesskey="t" class="new ca-talk">Discussion</a></div>
						</div>
					</div>
					<!-- views -->
					<div id="p-views" class="p-views">
						<div class="tab-group">
							<div id="ca-formedit"><a href="/w/index.php?title=Traumatic_Glaucoma&amp;action=formedit" title="Edit this page with a form [&amp;]" accesskey="&amp;" class="ca-formedit">View form</a></div>
							<div id="ca-viewsource"><a href="/w/index.php?title=Traumatic_Glaucoma&amp;action=edit" title="This page is protected.&#10;You can view its source [e]" accesskey="e" class="ca-viewsource">View source</a></div>
							<div id="ca-history"><a href="/w/index.php?title=Traumatic_Glaucoma&amp;action=history" title="Past revisions of this page [h]" accesskey="h" class="ca-history">History</a></div>
						</div>
					</div>
				</div>
			</div>
		</div>
		<div class="row">
			<div class="col-auto mx-auto col">

			</div>
		</div>
		<div class="row">
			<div class="col-auto mx-auto col">
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- start the content area -->
				<div id="content" class="mw-body content"><a id="top" class="top"></a>
					<div id="mw-indicators" class="mw-indicators">
					<div id="mw-indicator-smw-entity-examiner" class="mw-indicator mw-indicator-smw-entity-examiner"><div class="smw-entity-examiner smw-indicator-vertical-bar-loader" data-subject="Traumatic_Glaucoma#0##" data-dir="ltr" data-uselang="" title="Running an examiner in the background"></div></div>
				</div>
						<div class="contentHeader">
						<!-- title of the page -->
						<h1 id="firstHeading" class="firstHeading">Traumatic Glaucoma</h1>
						<!-- tagline; usually goes something like "From WikiName" primary purpose of this seems to be for printing to identify the source of the content -->
						<div id="siteSub" class="siteSub">From EyeWiki</div><div id="jump-to-nav" class="mw-jump jump-to-nav">Jump to:<a href="#mw-navigation">navigation</a>, <a href="#p-search">search</a></div>
					</div>
					<div id="bodyContent" class="bodyContent">
						<!-- body text -->

						<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><div class="mw-parser-output"><div id="article-header" data-description2-ignore=""><div id="contest" style="margin-bottom: 6px;">
</div>
<div class="infobox contributors">
<div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header"><a href="/Property:Authors" title="Property:Authors">Article initiated by</a>:
</div>
<div class="info-section-body"><a href="/User:Albertkhouri" title="User:Albertkhouri">Albert S Khouri, MD</a>,&#8201;<a href="/w/index.php?title=User:Mina_Mikhael&amp;action=formedit&amp;redlink=1" class="new" title="User:Mina Mikhael (page does not exist)">Mina Mikhael</a>
</div>
</div>
<div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header">All authors and contributors:
</div>
<div class="info-section-body"> <a href="/User:Albertkhouri" title="User:Albertkhouri">Albert S Khouri, MD</a>,&#160;<a href="/User:Anna.Murchison" title="User:Anna.Murchison">Anna Murchison, MD, MPH</a>,&#160;<a href="/User:Grant.Justin" title="User:Grant.Justin">Grant A. Justin, MD</a>,&#160;<a href="/User:Fasika.Woreta" title="User:Fasika.Woreta">Fasika A. Woreta, MD</a>,&#160;<a href="/User:Ohoud.Owaidhah" title="User:Ohoud.Owaidhah">Ohoud A Owaidhah, MD</a>
</div>
</div>
<div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header">Assigned editor:
</div>
<div class="info-section-body"> <a href="/User:Ohoud.Owaidhah" title="User:Ohoud.Owaidhah">Ohoud A Owaidhah, MD</a>,&#32;<a href="/User:Grant.Justin" title="User:Grant.Justin">Grant A. Justin, MD</a></div>
</div><div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header">Review:
</div>
<div class="info-section-body">Assigned status <b>Up to Date</b>
</div>
</div>&#160;by <a href="/User:Ohoud.Owaidhah" title="User:Ohoud.Owaidhah">Ohoud A Owaidhah, MD</a> on February 3, 2023.
</div>
<div style="display:none;">
<table cellspacing="5">

<tbody><tr>
<td><small><a rel="nofollow" class="external text" href="https://eyewiki.org/w/index.php?title=Traumatic_Glaucoma&amp;action=formedit">add</a></small>
</td></tr>
<tr>
<th align="right"><b><a href="/Property:Contributing_Editors" title="Property:Contributing Editors">Contributing Editors</a>:</b>
</th>
<td><small><a rel="nofollow" class="external text" href="https://eyewiki.org/w/index.php?title=Traumatic_Glaucoma&amp;action=formedit">add</a></small>
</td></tr>
</tbody></table> </div>
<div style="display:none;">
<p><br />
</p>
</div>
<div id="local-videos">
</div>
</div>
<div id="toc" class="toc" role="navigation" aria-labelledby="mw-toc-heading"><input type="checkbox" role="button" id="toctogglecheckbox" class="toctogglecheckbox" style="display:none" /><div class="toctitle" lang="en" dir="ltr"><h2 id="mw-toc-heading">Contents</h2><span class="toctogglespan"><label class="toctogglelabel" for="toctogglecheckbox"></label></span></div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Definition"><span class="tocnumber">1</span> <span class="toctext">Definition</span></a></li>
<li class="toclevel-1 tocsection-2"><a href="#Incidence_and_prevalence"><span class="tocnumber">2</span> <span class="toctext">Incidence and prevalence</span></a></li>
<li class="toclevel-1 tocsection-3"><a href="#Classification"><span class="tocnumber">3</span> <span class="toctext">Classification</span></a></li>
<li class="toclevel-1 tocsection-4"><a href="#Etiology_and_pathophysiology"><span class="tocnumber">4</span> <span class="toctext">Etiology and pathophysiology</span></a>
<ul>
<li class="toclevel-2 tocsection-5"><a href="#Traumatic_Glaucoma_secondary_to_Blunt_trauma"><span class="tocnumber">4.1</span> <span class="toctext">Traumatic Glaucoma secondary to Blunt trauma</span></a>
<ul>
<li class="toclevel-3 tocsection-6"><a href="#Early_onset_Glaucoma_pathophysiology"><span class="tocnumber">4.1.1</span> <span class="toctext">Early onset Glaucoma pathophysiology</span></a></li>
<li class="toclevel-3 tocsection-7"><a href="#Late_onset_Glaucoma_pathophysiology"><span class="tocnumber">4.1.2</span> <span class="toctext">Late onset Glaucoma pathophysiology</span></a></li>
</ul>
</li>
<li class="toclevel-2 tocsection-8"><a href="#Traumatic_Glaucoma_secondary_to_Penetrating_injury"><span class="tocnumber">4.2</span> <span class="toctext">Traumatic Glaucoma secondary to Penetrating injury</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-9"><a href="#Diagnostic_Workup"><span class="tocnumber">5</span> <span class="toctext">Diagnostic Workup</span></a>
<ul>
<li class="toclevel-2 tocsection-10"><a href="#History"><span class="tocnumber">5.1</span> <span class="toctext">History</span></a></li>
<li class="toclevel-2 tocsection-11"><a href="#Physical_Exam"><span class="tocnumber">5.2</span> <span class="toctext">Physical Exam</span></a></li>
<li class="toclevel-2 tocsection-12"><a href="#Ocular_imaging"><span class="tocnumber">5.3</span> <span class="toctext">Ocular imaging</span></a></li>
<li class="toclevel-2 tocsection-13"><a href="#Diagnostic_Taps"><span class="tocnumber">5.4</span> <span class="toctext">Diagnostic Taps</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-14"><a href="#Management"><span class="tocnumber">6</span> <span class="toctext">Management</span></a>
<ul>
<li class="toclevel-2 tocsection-15"><a href="#Traumatic_Glaucoma_secondary_to_Blunt_trauma_2"><span class="tocnumber">6.1</span> <span class="toctext">Traumatic Glaucoma secondary to Blunt trauma</span></a>
<ul>
<li class="toclevel-3 tocsection-16"><a href="#Early_onset_Glaucoma_management"><span class="tocnumber">6.1.1</span> <span class="toctext">Early onset Glaucoma management</span></a></li>
<li class="toclevel-3 tocsection-17"><a href="#Late_onset_Glaucoma_management"><span class="tocnumber">6.1.2</span> <span class="toctext">Late onset Glaucoma management</span></a></li>
</ul>
</li>
<li class="toclevel-2 tocsection-18"><a href="#Traumatic_Glaucoma_secondary_to_Penetrating_injury_2"><span class="tocnumber">6.2</span> <span class="toctext">Traumatic Glaucoma secondary to Penetrating injury</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-19"><a href="#References"><span class="tocnumber">7</span> <span class="toctext">References</span></a></li>
</ul>
</div>

<h1><span class="mw-headline" id="Definition">Definition</span></h1>
<p>Traumatic glaucoma is a type of secondary  glaucoma that develops following blunt or penetrating ocular trauma. This subtype of glaucoma usually entails several mechanisms that interplay to produce increased intraocular pressure (IOP)  and it is important to consider all the pathophysiological mechanisms leading to increased IOP as they influence management of patients. Furthermore, it is important to recognize traumatic glaucoma given the significant number of patients affected every year as discussed in the incidence and prevalence sections below. 
</p>
<h1><span class="mw-headline" id="Incidence_and_prevalence">Incidence and prevalence</span></h1>
<p>The risk of developing glaucoma after penetrating injury is estimated to be 2.67%, while it is 3.39% after blunt trauma according to latest studies in the U.S.<sup id="cite_ref-:0_1-0" class="reference"><a href="#cite_note-:0-1">&#91;1&#93;</a></sup>. This constitutes a significant number of patients who are at risk of developing vision threatening glaucoma after trauma to the eye since the incidence of ocular trauma is around 2.5 million patients every year in the U.S.<sup id="cite_ref-:1_2-0" class="reference"><a href="#cite_note-:1-2">&#91;2&#93;</a></sup>. Traumatic injuries are particularly prevalent among certain age groups like the elderly with falls leading to globe injury and younger individuals with injuries related to sports or assault.   
</p>
<h1><span class="mw-headline" id="Classification">Classification</span></h1>
<p>Glaucoma after trauma can be classified into two broad categories; occurring after blunt or after penetrating trauma. Glaucoma occurring after blunt trauma can be further classified into early onset and late onset glaucoma<sup id="cite_ref-:2_3-0" class="reference"><a href="#cite_note-:2-3">&#91;3&#93;</a></sup>. Other entities of post traumatic glaucoma include post chemical, thermal, electric and radiation injury<sup id="cite_ref-:2_3-1" class="reference"><a href="#cite_note-:2-3">&#91;3&#93;</a></sup>.     
</p>
<h1><span class="mw-headline" id="Etiology_and_pathophysiology">Etiology and pathophysiology</span></h1>
<p>There are many etiologies for increased IOP in traumatic glaucoma due to the pathophysiology and healing responses that occur after injury to the eye. Therefore, the pathophysiology of increased IOP will be discussed separately for each entity of post traumatic glaucoma taking the above mentioned classification as a framework. It is important to keep in mind though that several of these mechanisms might be present at the same time thus contributing to the increased IOP.
</p>
<h2><span class="mw-headline" id="Traumatic_Glaucoma_secondary_to_Blunt_trauma">Traumatic Glaucoma secondary to Blunt trauma</span></h2>
<h3><span class="mw-headline" id="Early_onset_Glaucoma_pathophysiology">Early onset Glaucoma pathophysiology</span></h3>
<p><b>1)Trabecular meshwork disruption:</b>
</p><p>The trabecular meshwork can get mechanically disrupted following globe trauma. On gonioscopy, superficial tears may be visualized and often manifest as trabecular flaps that are hinged at the level of the scleral spur<sup id="cite_ref-:1_2-1" class="reference"><a href="#cite_note-:1-2">&#91;2&#93;</a></sup>.  Full thickness tears might be seen on gonioscopy as torn iris processes or blood in the angle or in Schlemm's canal<sup id="cite_ref-:1_2-2" class="reference"><a href="#cite_note-:1-2">&#91;2&#93;</a></sup>. These changes may not lead to an immediate and prolonged increase in IOP and may eventually resolve over time. However, the healing process leading to scarring from ciliary muscle disruption and angle injury along with trabecular meshwork tears might lead to late onset rise in IOP due to damage to the outflow apparatus and decreased draining of aqueous humor. Moreover, in certain injuries, a decrease in IOP might be observed due to the disruption of the ciliary body attachment to the scleral spur leading to a ciliary body cleft. Careful gonioscopy is essential for the diagnosis of angle recession and ciliary body clefts.
</p><p><b>2) Hyphema:</b> 
</p><p>The source of bleeding is proposed to occur through two main mechanisms. First, the initial trauma to the globe leads to anteroposterior compression of the globe with simultaneous equatorial expansion leading to tearing of the blood vessels of the ciliary body and stromal iris<sup id="cite_ref-:1_2-3" class="reference"><a href="#cite_note-:1-2">&#91;2&#93;</a></sup>. Another mechanism is the sudden rise of IOP leading to damage of the fragile blood vessels of the iris/ciliary body<sup id="cite_ref-:2_3-2" class="reference"><a href="#cite_note-:2-3">&#91;3&#93;</a></sup>. The accumulation of blood in the anterior chamber <b>(Figure 1)</b> leads to obstruction of the trabecular meshwork with erythrocytes, fibrin, platelets and other inflammatory debris (by products of fibrinolysis) and this might later lead to prolonged increase in the IOP<sup id="cite_ref-:2_3-3" class="reference"><a href="#cite_note-:2-3">&#91;3&#93;</a></sup>. In cases where the patient is a carrier of sickle cell trait, even small amounts of RBCs in the anterior chamber might lead to significant increase in IOP since sickle cells tend to deform and block trabecular meshwork to a greater extent than normal healthy RBCs<sup id="cite_ref-:0_1-1" class="reference"><a href="#cite_note-:0-1">&#91;1&#93;</a></sup>. Obtaining a sickle cell test is paramount to diagnosis and proper treatment particularly in avoiding medications that may induce further sickle crisis like oral carbonic anhydrase inhibitors and in ensuring patients remain properly hydrated.
</p>
<div class="center"><div class="thumb tnone"><div class="thumbinner" style="width:340px;"><a href="/File:1E1BF204-3AF2-4B51-8837-323F40F9E592.JPEG" class="image"><img alt="" src="/w/images/1/thumb/9/96/1E1BF204-3AF2-4B51-8837-323F40F9E592.JPEG/338px-1E1BF204-3AF2-4B51-8837-323F40F9E592.JPEG" decoding="async" width="338" height="345" class="thumbimage" srcset="/w/images/1/thumb/9/96/1E1BF204-3AF2-4B51-8837-323F40F9E592.JPEG/507px-1E1BF204-3AF2-4B51-8837-323F40F9E592.JPEG 1.5x, /w/images/1/thumb/9/96/1E1BF204-3AF2-4B51-8837-323F40F9E592.JPEG/675px-1E1BF204-3AF2-4B51-8837-323F40F9E592.JPEG 2x" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/File:1E1BF204-3AF2-4B51-8837-323F40F9E592.JPEG" class="internal" title="Enlarge"></a></div><b>Figure 1.</b> Traumatic hyphema with blood clots in the angle and the anterior chamber. Note that elevated IOP has lead to corneal edema and a hazy view into the anterior chamber (Image courtesy of Albert S. Khouri, MD, Rutgers NJMS Ophthalmology Department).</div></div></div></div>
<p><b>3)Traumatic Iritis:</b>  
</p><p>Blunt trauma might lead to inflammation of the iris leading to compromise of the blood aqueous barrier and leakage of proteins and white blood cells that may then increase resistance at the trabecular meshwork leading to a rise in IOP. Trauma also might lead to direct inflammation of the trabecular meshwork (trabeculitis) leading to decrease in aqueous outflow<sup id="cite_ref-:1_2-4" class="reference"><a href="#cite_note-:1-2">&#91;2&#93;</a></sup>. 
</p><p><b>4)Choroidal hemorrhage:</b> 
</p><p>This is a cause of acute increase in IOP following severe eye trauma<sup id="cite_ref-:0_1-2" class="reference"><a href="#cite_note-:0-1">&#91;1&#93;</a></sup> or in patients who are on anticoagulation. The mechanism of increased IOP is related to the mass effect in the posterior segment leading to forward displacement of the lens-iris diaphragm by the choroidal hemorrhage leading to angle closure glaucoma<sup id="cite_ref-4" class="reference"><a href="#cite_note-4">&#91;4&#93;</a></sup>. 
</p>
<h3><span class="mw-headline" id="Late_onset_Glaucoma_pathophysiology">Late onset Glaucoma pathophysiology</span></h3>
<p><b>1)Angle-Recession:</b>  
</p><p>Angle recession is defined as a tear that occurs between the longitudinal and circular layers of the ciliary muscles leading to a widened ciliary body band that can be seen on gonioscopy<sup id="cite_ref-:3_5-0" class="reference"><a href="#cite_note-:3-5">&#91;5&#93;</a></sup>. It is postulated that this damage in the ciliary muscle signifies a more prominent damage in the trabecular meshwork<sup id="cite_ref-:0_1-3" class="reference"><a href="#cite_note-:0-1">&#91;1&#93;</a></sup>. Such damage in the trabecular meshwork leads to scarring and decrease in the outflow of aqueous humor leading to increase IOP over time. Angle recession of greater than 180° leads to an increased risk of glaucoma <sup id="cite_ref-:3_5-1" class="reference"><a href="#cite_note-:3-5">&#91;5&#93;</a></sup>.  
</p><p><b>2)Ghost cell Glaucoma:</b> 
</p><p>This form of secondary glaucoma occurs following trauma causing bleeding in the vitreous cavity<sup id="cite_ref-:0_1-4" class="reference"><a href="#cite_note-:0-1">&#91;1&#93;</a></sup>. One to three weeks after the initial trauma, the red blood cells change their shape and consistency becoming spherical, rigid and containing Heinz bodies (degenerated hemoglobin)<sup id="cite_ref-:0_1-5" class="reference"><a href="#cite_note-:0-1">&#91;1&#93;</a></sup>.  Those rigid cells are called ghost cells and being rigid and non flexible, these cells clog the trabecular meshwork leading to increased IOP<sup id="cite_ref-:4_6-0" class="reference"><a href="#cite_note-:4-6">&#91;6&#93;</a></sup>. The ghost cells reach the anterior chamber through a disrupted anterior hyaloid face after trauma<sup id="cite_ref-:4_6-1" class="reference"><a href="#cite_note-:4-6">&#91;6&#93;</a></sup>. Ghost cells do not form, however, in the case of anterior chamber bleeding due to the the high oxygen pressure in the anterior chamber and the rapid circulation<sup id="cite_ref-:4_6-2" class="reference"><a href="#cite_note-:4-6">&#91;6&#93;</a></sup>.
</p><p><b>3)Hemolytic Glaucoma (Rare):</b>
</p><p>This form of glaucoma is due to the hemolysis of red blood cells from bleeding in the vitreous body. The released debris, free hemoglobin and macrophages laden with hemoglobin obstruct the trabecular meshwork<sup id="cite_ref-:0_1-6" class="reference"><a href="#cite_note-:0-1">&#91;1&#93;</a></sup>. The difference from ghost cell glaucoma is in the absence of ghost cells in the trabecular meshwork (on careful slit lamp examination or on histopathologic evaluation of anterior chamber aspirate which is mostly of academic interest and not performed clinically).
</p><p><b>4)Hemosiderotic Glaucoma (Very Rare):</b> 
</p><p>This form of glaucoma is caused by the toxic effects of iron on the cell of the trabecular meshwork. The source of the iron is either longstanding bleeding in the vitreous body or a retained foreign body containing iron<sup id="cite_ref-:0_1-7" class="reference"><a href="#cite_note-:0-1">&#91;1&#93;</a></sup>. 
</p><p><b>5)Lens dislocation/subluxation:</b>   
</p><p>Globe trauma may lead to the anterior dislocation of the lens leading to pupillary block and acute angle closure glaucoma<sup id="cite_ref-:1_2-5" class="reference"><a href="#cite_note-:1-2">&#91;2&#93;</a></sup>. In some cases, the lens might dislocate posteriorly leading to vitreous prolapse into the anterior chamber and pupil block glaucoma<sup id="cite_ref-:1_2-6" class="reference"><a href="#cite_note-:1-2">&#91;2&#93;</a></sup>. According to Masaru et al., most cases of glaucoma secondary to lens subluxation are of the open angle type<sup id="cite_ref-:5_7-0" class="reference"><a href="#cite_note-:5-7">&#91;7&#93;</a></sup>. Postulated mechanisms for open angle glaucoma secondary to traumatic subluxation are; intermittent closure of the angle by the dislocated lens, intraocular inflammation associated with uveitis secondary to the dislocated lens, occult phacolytic glaucoma (described below) or obstruction of the trabecular meshwork by vitreous displaced in the anterior chamber<sup id="cite_ref-:5_7-1" class="reference"><a href="#cite_note-:5-7">&#91;7&#93;</a></sup>.   
</p><p><b>6)Phacolytic Glaucoma:</b>
</p><p>In the trauma setting, a traumatic mature cataract (but more commonly a mature cataract without history of trauma) may lead to leakage of proteins through an intact lens capsule causing glaucoma <b>(Figure 2)</b> due to the trabecular meshwork being overwhelmed with inflammatory cells and proteinaceous debris<sup id="cite_ref-:6_8-0" class="reference"><a href="#cite_note-:6-8">&#91;8&#93;</a></sup>. Those proteins lead to an intense inflammatory response in the trabecular meshwork in response to their high molecular weight nature leading to blockage of the meshwork with inflammatory cells and leaked proteins<sup id="cite_ref-:6_8-1" class="reference"><a href="#cite_note-:6-8">&#91;8&#93;</a></sup>.
</p>
<div class="center"><div class="thumb tnone"><div class="thumbinner" style="width:319px;"><a href="/File:IMG_1376.JPG" class="image"><img alt="" src="/w/images/1/thumb/9/90/IMG_1376.JPG/317px-IMG_1376.JPG" decoding="async" width="317" height="317" class="thumbimage" srcset="/w/images/1/thumb/9/90/IMG_1376.JPG/476px-IMG_1376.JPG 1.5x, /w/images/1/thumb/9/90/IMG_1376.JPG/634px-IMG_1376.JPG 2x" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/File:IMG_1376.JPG" class="internal" title="Enlarge"></a></div><b>Figure 2.</b> Traumatic phacolytic glaucoma showing a wrinkled anterior lens capsule due to seepage of lens proteins. The lens shows a mature cataract. Cataract extraction lead to the resolution of glaucoma&#160;(Image courtesy of Albert S Khouri, MD, Rutgers NJMS Ophthalmology Department).</div></div></div></div>
<h2><span class="mw-headline" id="Traumatic_Glaucoma_secondary_to_Penetrating_injury">Traumatic Glaucoma secondary to Penetrating injury</span></h2>
<p>Penetrating injuries will lead to glaucoma through many mechanisms including ones that are already discussed in the blunt trauma section. Those mechanisms include presence of a hyphema, lens dislocation, phacolytic or ghost cell glaucoma<sup id="cite_ref-:1_2-7" class="reference"><a href="#cite_note-:1-2">&#91;2&#93;</a></sup>. 
</p><p>Other mechanisms include; 
</p>
<ol><li>Injury to the cornea leading to a shallow anterior chamber which in the setting of significant inflammation might lead to extensive anterior synechiae producing secondary angle closure glaucoma<sup id="cite_ref-:1_2-8" class="reference"><a href="#cite_note-:1-2">&#91;2&#93;</a></sup>.</li>
<li>Posterior synechiae can also occur with seclusion of the pupil and iris bombe leading to secondary angle closure glaucoma<sup id="cite_ref-:1_2-9" class="reference"><a href="#cite_note-:1-2">&#91;2&#93;</a></sup>.</li>
<li>Injury to the lens with disruption of the lens capsule can lead to severe inflammation due to liberation of lens material within the globe. Lens particles can also mechanically obstruct the trabecular meshwork.</li>
<li>Hydrated lens with an enlarged anteroposterior dimension can lead to anterior iris bowing and angle closure.</li>
<li>Penetrating trauma might create a conduit for the epithelial cells to get into the anterior chamber leading to epithelial down growth in the anterior chamber and obstruction of the meshwork by epithelial sheets of cells<sup id="cite_ref-:0_1-8" class="reference"><a href="#cite_note-:0-1">&#91;1&#93;</a></sup>. Anterior synechiae might also result from contracting epithelial cells leading to angle closure glaucoma<sup id="cite_ref-:0_1-9" class="reference"><a href="#cite_note-:0-1">&#91;1&#93;</a></sup>.</li>
<li>Retained foreign bodies containing iron might produce siderotic glaucoma due to the toxic effect of iron on cells of the trabecular meshwork<sup id="cite_ref-:0_1-10" class="reference"><a href="#cite_note-:0-1">&#91;1&#93;</a></sup>.    As is evident from the above, depending on the nature and extent of the penetrating injury, the mechanisms leading to glaucoma can be multiple, complex and inter-related.</li></ol>
<h1><span class="mw-headline" id="Diagnostic_Workup">Diagnostic Workup</span></h1>
<h2><span class="mw-headline" id="History">History</span></h2>
<p>Obtaining an elaborate history is important to identify the setting and nature (blunt vs penetrating), the severity and possibility of an intraocular foreign body (e.g., high speed projectiles like shrapnel, glass, bullets or balls<sup id="cite_ref-:7_9-0" class="reference"><a href="#cite_note-:7-9">&#91;9&#93;</a></sup>), the timeline for developing increased IOP (e.g., delayed with angle recession and acute with hyphema or lens fragment), the setting of the injury (school, work, etc.<sup id="cite_ref-:7_9-1" class="reference"><a href="#cite_note-:7-9">&#91;9&#93;</a></sup>) and past ocular history (e.g., patients with history of cataract or pre-existing glaucoma)<sup id="cite_ref-:7_9-2" class="reference"><a href="#cite_note-:7-9">&#91;9&#93;</a></sup>. All of this will help guide the physical exam and identify the mechanisms of increased IOP and hence will help directing the management.
</p>
<h2><span class="mw-headline" id="Physical_Exam">Physical Exam</span></h2>
<ul><li><b>Visual Acuity assessment</b></li>
<li><b>Visual inspection</b> of the globe and adnexa for signs of retained foreign bodies.</li>
<li><b>Slit lamp exam</b>:
<ul><li>Conjunctiva: Apparent or occult lacerations (self sealed) or hemorrhagic chemosis which may hide deeper penetrating lacerations or a foreign body.</li>
<li>Cornea: Laceration or entry of a foreign body, self sealed laceration with high velocity projectiles or corneal blood staining signifying a possibility of long standing bleeding and increased IOP.</li>
<li>Anterior chamber: Presence of hyphema, inflammatory cells and fibrin, debris (in iritis), shallow anterior chamber (in case of angle closure glaucoma), reddish - brown RBCs (in hemolytic glaucoma)<sup id="cite_ref-:1_2-10" class="reference"><a href="#cite_note-:1-2">&#91;2&#93;</a></sup>and anterior synechiae or peripheral synechiae. Careful examination for foreign material (lashes, glass, other foreign bodies or lens particles in case of lens damage).</li>
<li>Iris: Iridodialysis (in case of angle recession) <b>(Figure 3)</b>, sphincter tears or iris transillumination defects (with foreign body suspicion).</li>
<li>Lens: Lens subluxation, phacodonesis (in lens dislocation)<sup id="cite_ref-:0_1-11" class="reference"><a href="#cite_note-:0-1">&#91;1&#93;</a></sup>, lens opacification (localized or diffuse), damage to lens capsule, pigment or blood within the lens or on the lens surface or vitreous prolapse around zonular damage among others. <div class="center"><div class="thumb tnone"><div class="thumbinner" style="width:319px;"><a href="/File:IMG_1223.JPG" class="image"><img alt="" src="/w/images/1/thumb/a/a8/IMG_1223.JPG/317px-IMG_1223.JPG" decoding="async" width="317" height="423" class="thumbimage" srcset="/w/images/1/thumb/a/a8/IMG_1223.JPG/477px-IMG_1223.JPG 1.5x, /w/images/1/thumb/a/a8/IMG_1223.JPG/635px-IMG_1223.JPG 2x" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/File:IMG_1223.JPG" class="internal" title="Enlarge"></a></div><b>Figure 3</b>. Surgical repair of a traumatic iridodialysis (Images courtesy of Albert S Khouri, MD, Rutgers NJMS Ophthalmology Department).</div></div></div></div></li>
<li>Vitreous: Prolapse, pigment (tobacco dust denoting posterior segment RD), foreign material, blood or reduced red reflex and retrolenticular mass (in choroidal hemorrhage). If view to the fundus is precluded, then a CT scan is indicated. Once globe penetration is excluded a B scan ultrasound is indicated. Magnetic Resonance Imaging is clearly contraindicated if a metallic foreign body is suspected.</li></ul></li>
<li><b>Gonioscopy</b>:  Careful Gonioscopy should be performed once globe penetration is ruled out in order to examine the angle for traumatic injury (blood, recession, cleft) and to rule out a foreign body (if suspected) that may be lodged in the angle and not visible on slit lamp examination.
<ul><li>Gonioscopic signs of injury include:
<ul><li><ol><li>Iris root displacement posteriorly and a widened ciliary body face (in angle resection)<sup id="cite_ref-:0_1-12" class="reference"><a href="#cite_note-:0-1">&#91;1&#93;</a></sup>.</li>
<li>White- gray membrane covering the angle (also in angle resection)<sup id="cite_ref-:0_1-13" class="reference"><a href="#cite_note-:0-1">&#91;1&#93;</a></sup>.</li>
<li>Cyclodialysis cleft<sup id="cite_ref-:1_2-11" class="reference"><a href="#cite_note-:1-2">&#91;2&#93;</a></sup> (disinsertion of the ciliary body from the sclera leading to aqueous flow to the suprachoroidal space and often associated with hypotony).</li>
<li>Trabecular meshwork flaps that are hinged at the level of the scleral spur (in superficial tears of trabecular meshwork disruption) <sup id="cite_ref-:1_2-12" class="reference"><a href="#cite_note-:1-2">&#91;2&#93;</a></sup>.</li>
<li>Torn iris processes with blood in the angle (in angle recession)<sup id="cite_ref-:1_2-13" class="reference"><a href="#cite_note-:1-2">&#91;2&#93;</a></sup>.</li></ol></li></ul></li></ul></li></ul>
<h2><span class="mw-headline" id="Ocular_imaging">Ocular imaging</span></h2>
<ul><li>As mentioned earlier, Ultrasonography (B-scan is a 2 dimensional ultrasound scan. A-scan is a single beam of ultrasound that is meant to better identify the acoustic nature of the imaged ocular tissues. A-scan is useful if a suspected intraocular foreign body exists as hard matter like glass or metal will display a higher signal intensity versus blood clots or ocular tissues, for example) for posterior segment imaging.</li>
<li>Ultrasound Biomicroscopy (UBM: provides ultrasound examination of the anterior segment including the ciliary body and can be useful in the identification of a ciliary body cleft) <b>(Figure 4).</b></li>
<li>Anterior segment OCT, CT and MRI (MRI can only be performed once a magnetic FB is ruled out).</li>
<li>All those modalities are used to provide useful information when physical exam and gonioscopy are non conclusive, when physical exam is not possible or when ocular structures are masked for example by hyphema or vitreous hemorrhage<sup id="cite_ref-:1_2-14" class="reference"><a href="#cite_note-:1-2">&#91;2&#93;</a></sup>.</li></ul>
  <div class="center"><div class="thumb tnone"><div class="thumbinner" style="width:306px;"><a href="/File:E33E23C7-3D9F-46EE-9824-7FA6C9F854D6.JPEG" class="image"><img alt="" src="/w/images/1/thumb/b/b4/E33E23C7-3D9F-46EE-9824-7FA6C9F854D6.JPEG/304px-E33E23C7-3D9F-46EE-9824-7FA6C9F854D6.JPEG" decoding="async" width="304" height="412" class="thumbimage" srcset="/w/images/1/thumb/b/b4/E33E23C7-3D9F-46EE-9824-7FA6C9F854D6.JPEG/456px-E33E23C7-3D9F-46EE-9824-7FA6C9F854D6.JPEG 1.5x, /w/images/1/thumb/b/b4/E33E23C7-3D9F-46EE-9824-7FA6C9F854D6.JPEG/608px-E33E23C7-3D9F-46EE-9824-7FA6C9F854D6.JPEG 2x" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/File:E33E23C7-3D9F-46EE-9824-7FA6C9F854D6.JPEG" class="internal" title="Enlarge"></a></div><b>Figure 4.</b> Ultrasound Biomicroscopy showing anterior chamber angle appositional closure in a case with trauma and a mature cataract formation. No cleft is seen here (Image courtesy of Albert S Khouri, MD, Rutgers NJMS Ophthalmology Department).</div></div></div></div>
<h2><span class="mw-headline" id="Diagnostic_Taps">Diagnostic Taps</span></h2>
<p>Might be used only when the clinical picture is not conclusive for the mechanism of glaucoma. This might be useful when a histopathologic diagnosis is imperative for the management<sup id="cite_ref-:1_2-15" class="reference"><a href="#cite_note-:1-2">&#91;2&#93;</a></sup>. 
</p>
<h1><span class="mw-headline" id="Management">Management</span></h1>
<p>The main stay of glaucoma treatment is the reduction of IOP since elevated IOP remains the main risk factor for glaucomatous optic neuropathy. The treatment typically is through a stepwise approach where topical medications are instituted first. Depending on the severity of the IOP elevation and the degree of optic neuropathy, first line agents are instituted and then adjunctive agents are added until IOP is controlled (topical beta blockers, topical carbonic anhydrase inhibitors, and alpha agonists). Systemic glaucoma medications can be used to further control IOP like carbonic anhydrase inhibitors (orally or intravenously once sickle cell disease is ruled out) and hyperosmotic agents like mannitol (also caution needs to be exercise to avoid dehydration in elderly patients or patients with heart disease or sickle cell disease among others). Surgical interventions are needed when the disease is uncontrolled on medical therapy. Surgical management includes mainly tube shunting among other interventional methods. Tube shunting was found to have good outcomes in controlling IOP in post traumatic glaucoma that is not controlled with medical therapy<sup id="cite_ref-:8_10-0" class="reference"><a href="#cite_note-:8-10">&#91;10&#93;</a></sup>. Management of post traumatic glaucoma is aimed mainly at the main underlying mechanism leading to increased IOP. Therefore, management will be discussed within the framework of pathophysiological mechanism discussed above.
</p>
<h2><span class="mw-headline" id="Traumatic_Glaucoma_secondary_to_Blunt_trauma_2">Traumatic Glaucoma secondary to Blunt trauma</span></h2>
<h3><span class="mw-headline" id="Early_onset_Glaucoma_management">Early onset Glaucoma management</span></h3>
<p><b>1)Trabecular meshwork disruption:</b>
</p><p>This type of injury is a common cause of early increase in IOP in cases of blunt trauma<sup id="cite_ref-:1_2-16" class="reference"><a href="#cite_note-:1-2">&#91;2&#93;</a></sup>.The management is typically limited to medical management to counteract the initial increase in IOP<sup id="cite_ref-:1_2-17" class="reference"><a href="#cite_note-:1-2">&#91;2&#93;</a></sup>.However, it is important to discuss with patients that if healing leads to angle recession then incremental medical therapy is indicated and incisional surgery might be required to resolve the long term increase in IOP<sup id="cite_ref-:1_2-18" class="reference"><a href="#cite_note-:1-2">&#91;2&#93;</a></sup>. 
</p><p><b>2)Hyphema:</b>
</p><p>The management of hyphema should be directed with the goal of preventing re-bleeding which will increase the chances of complications caused by hyphema like secondary glaucoma<sup id="cite_ref-:2_3-4" class="reference"><a href="#cite_note-:2-3">&#91;3&#93;</a></sup>(refer to eye wiki article on <a href="/Hyphema" title="Hyphema">hyphema</a> for detailed information about the management of hyphema). In the case of the development of glaucoma secondary to hyphema, the initial management should be directed at lowering IOP using medical therapy. Topical therapies like carbonic anhydrase inhibitors, alpha agonists and Beta-blockers or combination of these drugs are the first line therapy<sup id="cite_ref-:1_2-19" class="reference"><a href="#cite_note-:1-2">&#91;2&#93;</a></sup>. Prostaglandin analogs and miotic agents should be avoided since they may enhance the acute inflammatory process causing possibly more damage to the ocular structures<sup id="cite_ref-:0_1-14" class="reference"><a href="#cite_note-:0-1">&#91;1&#93;</a></sup>. Oral therapies like acetazolamide and methazolamide are used if topical therapy is not enough to control the IOP<sup id="cite_ref-:9_11-0" class="reference"><a href="#cite_note-:9-11">&#91;11&#93;</a></sup> (and after sickle disease is ruled out). Moreover, I.V Mannitol might also be used in the acute setting in patients where IOP is not controlled on topical therapy in symptomatic patients or in patients with pre-existing optic nerve damage that are at higher risk for loss of vision<sup id="cite_ref-:9_11-1" class="reference"><a href="#cite_note-:9-11">&#91;11&#93;</a></sup>.
</p><p>However, as mentioned earlier in patient with sickle cell disease acetazolamide and mannitol are avoided due to the risk of increased sickling caused by decreased blood pH (metabolic acidosis) or volume depletion<sup id="cite_ref-:9_11-2" class="reference"><a href="#cite_note-:9-11">&#91;11&#93;</a></sup>.
</p><p>Surgical intervention generally should be considered in the following cases<sup id="cite_ref-:0_1-15" class="reference"><a href="#cite_note-:0-1">&#91;1&#93;</a></sup><sup id="cite_ref-:1_2-20" class="reference"><a href="#cite_note-:1-2">&#91;2&#93;</a></sup><sup id="cite_ref-:9_11-3" class="reference"><a href="#cite_note-:9-11">&#91;11&#93;</a></sup>;
</p>
<ol><li>Resistant IOP despite maximum medical therapy.</li>
<li>Persistent 100&#160;% hyphema (also known as eight ball hyphema).</li>
<li>When hyphema is persistent for a period of days without signs of improvement: example more than 50&#160;% for 10-14 days (According to some guidelines).</li>
<li>Eyes manifesting early corneal blood staining.</li>
<li>Eyes in which there is a detection of active rebleeding.</li>
<li>Sickle cell anemia or trait.</li></ol>
<p> Among the surgical options, the most intuitive is an anterior chamber washout to evacuate the blood<sup id="cite_ref-:0_1-16" class="reference"><a href="#cite_note-:0-1">&#91;1&#93;</a></sup>. Trabeculectomy may also be used to normalize pressure<sup id="cite_ref-:0_1-17" class="reference"><a href="#cite_note-:0-1">&#91;1&#93;</a></sup> but tube shunt surgery remains the main stay surgical treatment<sup id="cite_ref-:8_10-1" class="reference"><a href="#cite_note-:8-10">&#91;10&#93;</a></sup>.
</p><p> <b>3)Traumatic Iritis:</b>
</p><p>The increased pressure is usually reversible and responds effectively to anti-inflammatory topical agents like steroids or NSAIDS<sup id="cite_ref-:1_2-21" class="reference"><a href="#cite_note-:1-2">&#91;2&#93;</a></sup>. Moreover, cycloplegics are used to decrease pain caused by the spasm of the ciliary body<sup id="cite_ref-:1_2-22" class="reference"><a href="#cite_note-:1-2">&#91;2&#93;</a></sup>. Topical glaucoma therapy is used to control IOP. 
</p><p><b>4)Choroidal hemorrhage:</b>
</p><p>The initial management should be directed at lowering the IOP using topical agents, oral carbonic anhydrase and systemic hyperosmotic agents as needed<sup id="cite_ref-:0_1-18" class="reference"><a href="#cite_note-:0-1">&#91;1&#93;</a></sup>. Cycloplegics will help in deepening the anterior chamber while steroids help reducing the inflammation and stabilize compromised choroidal vasculature<sup id="cite_ref-:0_1-19" class="reference"><a href="#cite_note-:0-1">&#91;1&#93;</a></sup>. Surgical drainage of the clot is indicated in case of persistent angle closure glaucoma with high IOP, large choroidals with retina apposition (“kissing choroidals”) or lens-cornea apposition<sup id="cite_ref-:0_1-20" class="reference"><a href="#cite_note-:0-1">&#91;1&#93;</a></sup>. 
</p>
<h3><span class="mw-headline" id="Late_onset_Glaucoma_management">Late onset Glaucoma management</span></h3>
<p><b>1)Angle-Recession:</b>
</p><p>Angle recession glaucoma usually present with late onset increase in IOP caused by fibrosis, degeneration and atrophy of the trabecular meshwork and the canal of Schlemn<sup id="cite_ref-:1_2-23" class="reference"><a href="#cite_note-:1-2">&#91;2&#93;</a></sup>. Therefore, it presents as a secondary chronic open angle glaucoma<sup id="cite_ref-:0_1-21" class="reference"><a href="#cite_note-:0-1">&#91;1&#93;</a></sup>. Medical therapy might be beneficial in lowering IOP, particularly if the recession is limited and did not involve the majority of the angle. Incisional surgeries including trabeculectomy with anti-metabolite and tube shunt surgery can be performed to control the IOP. Cyclodestructive procedures like diode laser cyclophotocoagulation (continuous wave or micropulse cyclophotocoagulation) are beneficial in refractory cases<sup id="cite_ref-:1_2-24" class="reference"><a href="#cite_note-:1-2">&#91;2&#93;</a></sup>. 
</p><p><b>2)Ghost cell Glaucoma:</b> 
</p><p>This mechanism is usually self limited and thus initial management revolves around the use of standard medical therapy to lower the IOP<sup id="cite_ref-:4_6-3" class="reference"><a href="#cite_note-:4-6">&#91;6&#93;</a></sup>. If the medical therapy fails to lower the IOP and in the case of the presence of a dense vitreous hemorrhage a pars plana vitrectomy is performed to remove the reservoir of ghost cells<sup id="cite_ref-:4_6-4" class="reference"><a href="#cite_note-:4-6">&#91;6&#93;</a></sup>. 
</p><p><b>3)Lens dislocation/subluxation/phacolytic glaucoma:</b>
</p><p>Initial management revolves around the relief of pupillary block caused by the lens through laser or surgical iridotomy<sup id="cite_ref-:0_1-22" class="reference"><a href="#cite_note-:0-1">&#91;1&#93;</a></sup>. In addition to medical therapy, lensectomy is indicated in cases of pupillary block or angle closure and when the lens is cataractous or hyper-mature<sup id="cite_ref-:5_7-2" class="reference"><a href="#cite_note-:5-7">&#91;7&#93;</a></sup>. <b>(Figure5)</b>
</p>
<div class="center"><div class="thumb tnone"><div class="thumbinner" style="width:319px;"><a href="/File:1549133888091.JPEG" class="image"><img alt="" src="/w/images/1/thumb/7/72/1549133888091.JPEG/317px-1549133888091.JPEG" decoding="async" width="317" height="341" class="thumbimage" srcset="/w/images/1/thumb/7/72/1549133888091.JPEG/476px-1549133888091.JPEG 1.5x, /w/images/1/thumb/7/72/1549133888091.JPEG/634px-1549133888091.JPEG 2x" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/File:1549133888091.JPEG" class="internal" title="Enlarge"></a></div><b>Figure 5.</b> Treatment of traumatic lens particle glaucoma with cataract extraction (penetrating globe injury with a corneal laceration seen here repaired with sutures) (Images courtesy of Albert S Khouri, MD, Rutgers NJMS Ophthalmology Department).</div></div></div></div>
<h2><span class="mw-headline" id="Traumatic_Glaucoma_secondary_to_Penetrating_injury_2">Traumatic Glaucoma secondary to Penetrating injury</span></h2>
<p>It is important to consider that preventive management is of importance in the case of glaucoma secondary to penetrating injury<sup id="cite_ref-:10_12-0" class="reference"><a href="#cite_note-:10-12">&#91;12&#93;</a></sup>. Hence, the use of Viscoelastic material is recommended during the repair of open globe injury in order to preserve the structure of the anterior chamber and lower risks of anterior synechiae<sup id="cite_ref-:10_12-1" class="reference"><a href="#cite_note-:10-12">&#91;12&#93;</a></sup>. Furthermore, anti-inflammatory therapy with topical steroids is essential in order to reduce the iritis and lower the risks of anterior and posterior synechiae formation<sup id="cite_ref-:10_12-2" class="reference"><a href="#cite_note-:10-12">&#91;12&#93;</a></sup>. The management guidelines are similar to the ones discussed above in the blunt trauma section. Medical therapy is the mainstay in the acute setting unless the lens is the culprit for elevated IOP in which case a lensectomy may be indicated (pupil block, lens subluxation or lens particle among others). 
</p><p>Surgical management involves prompt closure of the globe to maintain a water sealed laceration and lower risks of infection <b>(Videos 1 and 2)</b>. A high index of suspicion is essential to identify intraocular foreign bodies that need to be removed to prevent infection and degeneration due to oxidation (for example, hemosiderosis). The intraocular pressure is then monitored and managed often over the course of weeks to months to years after the injury with a paradigm that typically relies on the aforementioned medical then surgical interventions.
</p><p><iframe width="560" height="315" src="//www.youtube-nocookie.com/embed/dJhZ-iGFZHs" frameborder="0" allowfullscreen=""></iframe>
</p><p><b>Video1.</b>(Videos are courtesy of Albert S. Khouri, M.D, Rutgers NJMS Ophthalmology Department).
</p><p><iframe width="560" height="315" src="//www.youtube-nocookie.com/embed/knr4qKa1nMc" frameborder="0" allowfullscreen=""></iframe>
</p><p><b>Video2.</b>(Videos are courtesy of Albert S. Khouri, M.D, Rutgers NJMS Ophthalmology Department).
</p><p><br />
In the case of epithelial down growth, which is often identified weeks to months after the initial injury, treatment is challenging and the prognosis is usually guarded<sup id="cite_ref-:0_1-23" class="reference"><a href="#cite_note-:0-1">&#91;1&#93;</a></sup>. The surgical intervention aims to excise and remove the epithelial membrane and is often performed in conjunction with adjunctive cryotherapy<sup id="cite_ref-:1_2-25" class="reference"><a href="#cite_note-:1-2">&#91;2&#93;</a></sup>. In any case with a retained metallic foreign body within the globe, emergency surgery for removal of the foreign body should be done to prevent further complications<sup id="cite_ref-13" class="reference"><a href="#cite_note-13">&#91;13&#93;</a></sup><b>(Figure 6).</b>
</p>
<div class="center"><div class="thumb tnone"><div class="thumbinner" style="width:445px;"><a href="/File:IMG_2758.jpg" class="image"><img alt="" src="/w/images/1/thumb/f/fc/IMG_2758.jpg/443px-IMG_2758.jpg" decoding="async" width="443" height="279" class="thumbimage" srcset="/w/images/1/thumb/f/fc/IMG_2758.jpg/665px-IMG_2758.jpg 1.5x, /w/images/1/thumb/f/fc/IMG_2758.jpg/886px-IMG_2758.jpg 2x" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/File:IMG_2758.jpg" class="internal" title="Enlarge"></a></div><b>Figure 6.</b> Metallic penetrating foreign body noted in the nasal sclera in a construction worker who was not wearing protective eye wear. This patient underwent emergency surgery for removal of the metallic foreign body (Image courtesy of Albert S Khouri, MD, Rutgers NJMS Ophthalmology Department).</div></div></div></div>
<h1><span class="mw-headline" id="References">References</span></h1>
<div class="mw-references-wrap mw-references-columns"><ol class="references">
<li id="cite_note-:0-1"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:0_1-0">1.00</a></sup> <sup><a href="#cite_ref-:0_1-1">1.01</a></sup> <sup><a href="#cite_ref-:0_1-2">1.02</a></sup> <sup><a href="#cite_ref-:0_1-3">1.03</a></sup> <sup><a href="#cite_ref-:0_1-4">1.04</a></sup> <sup><a href="#cite_ref-:0_1-5">1.05</a></sup> <sup><a href="#cite_ref-:0_1-6">1.06</a></sup> <sup><a href="#cite_ref-:0_1-7">1.07</a></sup> <sup><a href="#cite_ref-:0_1-8">1.08</a></sup> <sup><a href="#cite_ref-:0_1-9">1.09</a></sup> <sup><a href="#cite_ref-:0_1-10">1.10</a></sup> <sup><a href="#cite_ref-:0_1-11">1.11</a></sup> <sup><a href="#cite_ref-:0_1-12">1.12</a></sup> <sup><a href="#cite_ref-:0_1-13">1.13</a></sup> <sup><a href="#cite_ref-:0_1-14">1.14</a></sup> <sup><a href="#cite_ref-:0_1-15">1.15</a></sup> <sup><a href="#cite_ref-:0_1-16">1.16</a></sup> <sup><a href="#cite_ref-:0_1-17">1.17</a></sup> <sup><a href="#cite_ref-:0_1-18">1.18</a></sup> <sup><a href="#cite_ref-:0_1-19">1.19</a></sup> <sup><a href="#cite_ref-:0_1-20">1.20</a></sup> <sup><a href="#cite_ref-:0_1-21">1.21</a></sup> <sup><a href="#cite_ref-:0_1-22">1.22</a></sup> <sup><a href="#cite_ref-:0_1-23">1.23</a></sup></span> <span class="reference-text">Yanoff, Myron, MD, Duker, Jay S., MD.&#160;Ophthalmology, Fifth Edition.Philadelphia, Pennsylvania: Elsevier Inc; 2019:1089-1094.clinicalkey-com.proxy.libraries.rutgers.edu.web.25 July 2019.https://www-clinicalkeycom.proxy.libraries.rutgers.edu/#!/content/book/3-s2.0-B9780323528191003601.</span>
</li>
<li id="cite_note-:1-2"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:1_2-0">2.00</a></sup> <sup><a href="#cite_ref-:1_2-1">2.01</a></sup> <sup><a href="#cite_ref-:1_2-2">2.02</a></sup> <sup><a href="#cite_ref-:1_2-3">2.03</a></sup> <sup><a href="#cite_ref-:1_2-4">2.04</a></sup> <sup><a href="#cite_ref-:1_2-5">2.05</a></sup> <sup><a href="#cite_ref-:1_2-6">2.06</a></sup> <sup><a href="#cite_ref-:1_2-7">2.07</a></sup> <sup><a href="#cite_ref-:1_2-8">2.08</a></sup> <sup><a href="#cite_ref-:1_2-9">2.09</a></sup> <sup><a href="#cite_ref-:1_2-10">2.10</a></sup> <sup><a href="#cite_ref-:1_2-11">2.11</a></sup> <sup><a href="#cite_ref-:1_2-12">2.12</a></sup> <sup><a href="#cite_ref-:1_2-13">2.13</a></sup> <sup><a href="#cite_ref-:1_2-14">2.14</a></sup> <sup><a href="#cite_ref-:1_2-15">2.15</a></sup> <sup><a href="#cite_ref-:1_2-16">2.16</a></sup> <sup><a href="#cite_ref-:1_2-17">2.17</a></sup> <sup><a href="#cite_ref-:1_2-18">2.18</a></sup> <sup><a href="#cite_ref-:1_2-19">2.19</a></sup> <sup><a href="#cite_ref-:1_2-20">2.20</a></sup> <sup><a href="#cite_ref-:1_2-21">2.21</a></sup> <sup><a href="#cite_ref-:1_2-22">2.22</a></sup> <sup><a href="#cite_ref-:1_2-23">2.23</a></sup> <sup><a href="#cite_ref-:1_2-24">2.24</a></sup> <sup><a href="#cite_ref-:1_2-25">2.25</a></sup></span> <span class="reference-text">Tarek M Shaarawy&#160;PD MD MSc,Mark B Sherwood&#160;FRCP FRCS FRCOphth, Roger A Hitchings FRCS FRCOphthand&#160;Jonathan G Crowston&#160;PhD FRCOphth FRANZCO.&#160;Glaucoma, second Edition.&#160;Philadelphia, Pennsylvania: Elsevier Inc; 2015:446-456. clinicalkey-com.proxy.libraries.rutgers.edu.web.25 July 2019.https://www-clinicalkey-com.proxy.libraries.rutgers.edu/#!/content/book/3-s2.0-B9780702051937001308.</span>
</li>
<li id="cite_note-:2-3"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:2_3-0">3.0</a></sup> <sup><a href="#cite_ref-:2_3-1">3.1</a></sup> <sup><a href="#cite_ref-:2_3-2">3.2</a></sup> <sup><a href="#cite_ref-:2_3-3">3.3</a></sup> <sup><a href="#cite_ref-:2_3-4">3.4</a></sup></span> <span class="reference-text">Brandt MT, Haug RH. Traumatic hyphema: a comprehensive review. J Oral Maxillofac Surg 2001; 59:1462.</span>
</li>
<li id="cite_note-4"><span class="mw-cite-backlink"><a href="#cite_ref-4">↑</a></span> <span class="reference-text">YANG, SAM S. MD; FU, ARTHUR D. MD; McDONALD, H. RICHARD MD; JOHNSON, ROBERT N. MD; AI, EVERETT MD and JUMPER, J. MICHAEL MD. Massive Spontaneous Choroidal Hemorrhage.Retina.23(2):139-144, April 2003.</span>
</li>
<li id="cite_note-:3-5"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:3_5-0">5.0</a></sup> <sup><a href="#cite_ref-:3_5-1">5.1</a></sup></span> <span class="reference-text">Ng, D.SC., Ching, R.HY. &amp; Chan, C.WN. Int Ophthalmol (2015) 35: 107.&#160;<a rel="nofollow" class="external free" href="https://doi.org/10.1007/s10792-014-0027-5">https://doi.org/10.1007/s10792-014-0027-5</a></span>
</li>
<li id="cite_note-:4-6"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:4_6-0">6.0</a></sup> <sup><a href="#cite_ref-:4_6-1">6.1</a></sup> <sup><a href="#cite_ref-:4_6-2">6.2</a></sup> <sup><a href="#cite_ref-:4_6-3">6.3</a></sup> <sup><a href="#cite_ref-:4_6-4">6.4</a></sup></span> <span class="reference-text">Alamri A, Alkatan H, Aljadaan I. Traumatic Ghost Cell Glaucoma with Successful Resolution of Corneal Blood Staining Following Pars Plana Vitrectomy.&#160;<i>Middle East Afr J Ophthalmol</i>. 2016;23(3):271–273. doi:10.4103/0974-9233.180778</span>
</li>
<li id="cite_note-:5-7"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:5_7-0">7.0</a></sup> <sup><a href="#cite_ref-:5_7-1">7.1</a></sup> <sup><a href="#cite_ref-:5_7-2">7.2</a></sup></span> <span class="reference-text">Masaru Inatani, MD, Hidenobu Tanihara, MD, Megumi Honjo, MD, Noriaki Kido, MD, Yoshihito Honda, MD.&#160;Secondary glaucoma associated with crystalline lens subluxation.Journal of Cataract &amp; Refractive Surgery.&#160;Volume 26, Issue 10,&#160;October 2000, Pages 1533-1536.www.siencedirect-com.proxy.libraries.rutgers.edu.web.10 August 2019.<a rel="nofollow" class="external free" href="https://www-sciencedirectcom.proxy.libraries.rutgers.edu/science/article/pii/S0886335000004715?via%3Dihub">https://www-sciencedirectcom.proxy.libraries.rutgers.edu/science/article/pii/S0886335000004715?via%3Dihub</a>.</span>
</li>
<li id="cite_note-:6-8"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:6_8-0">8.0</a></sup> <sup><a href="#cite_ref-:6_8-1">8.1</a></sup></span> <span class="reference-text">Dhingra, D., Grover, S., Kapatia, G., Pandav, S. S., &amp; Kaushik, S. (2019). Phacolytic glaucoma: A nearly forgotten entity.&#160;<i>European Journal of Ophthalmology</i>.&#160;<a rel="nofollow" class="external free" href="https://doi.org/10.1177/1120672119841972">https://doi.org/10.1177/1120672119841972</a></span>
</li>
<li id="cite_note-:7-9"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:7_9-0">9.0</a></sup> <sup><a href="#cite_ref-:7_9-1">9.1</a></sup> <sup><a href="#cite_ref-:7_9-2">9.2</a></sup></span> <span class="reference-text">Gardiner, Matthew F., Susan B. Torrey MD, and Jonathan Trobe MD. "Approach to eye injuries in the emergency department."&#160;UpToDate. 26 July 2019 &lt;https://www.uptodate.com/contents/approach-to-eye-injuries-in-the-emergency department? source=history_widget&gt;.</span>
</li>
<li id="cite_note-:8-10"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:8_10-0">10.0</a></sup> <sup><a href="#cite_ref-:8_10-1">10.1</a></sup></span> <span class="reference-text">Yadgarov A, Liu D, Crane ES, Khouri AS. Surgical Outcomes of Ahmed or Baerveldt Tube Shunt Implantation for medically Uncontrolled Traumatic Glaucoma. J Curr Glaucoma Pract&#160;

2017;11(1):16-21.</span>
</li>
<li id="cite_note-:9-11"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:9_11-0">11.0</a></sup> <sup><a href="#cite_ref-:9_11-1">11.1</a></sup> <sup><a href="#cite_ref-:9_11-2">11.2</a></sup> <sup><a href="#cite_ref-:9_11-3">11.3</a></sup></span> <span class="reference-text">Christopher M Andreoli, MDMatthew F Gardiner, MD.Traumatic hyphema: Management.UpToDate. 10 August 2019. <a rel="nofollow" class="external free" href="https://www.uptodate.com/contents/traumatic-hyphema-management#H714240958">https://www.uptodate.com/contents/traumatic-hyphema-management#H714240958</a>.</span>
</li>
<li id="cite_note-:10-12"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:10_12-0">12.0</a></sup> <sup><a href="#cite_ref-:10_12-1">12.1</a></sup> <sup><a href="#cite_ref-:10_12-2">12.2</a></sup></span> <span class="reference-text">Osman, Essam A. “Glaucoma after open globe injury.”&#160;<i>Saudi journal of ophthalmology&#160;: official journal of the Saudi Ophthalmological Society</i>&#160;vol. 29,3 (2015): 222-4. doi:10.1016/j.sjopt.2014.10.006.</span>
</li>
<li id="cite_note-13"><span class="mw-cite-backlink"><a href="#cite_ref-13">↑</a></span> <span class="reference-text">Bloom WR, Ramsey JK, Ohr MP. Ocular Siderosis Secondary to Retained Intraocular Foreign Body: A Case Report.&#160;<i>Cureus</i>. 2019;11(5): e4660. Published 2019 May 14. doi:10.7759/cureus.4660.</span>
</li>
</ol></div>
<!-- 
NewPP limit report
Cached time: 20230306022530
Cache expiry: 86400
Dynamic content: false
Complications: [my_variables_no_cache]
[SMW] In‐text annotation parser time: 0.002 seconds
CPU time usage: 0.246 seconds
Real time usage: 0.266 seconds
Preprocessor visited node count: 1111/1000000
Post‐expand include size: 6640/2097152 bytes
Template argument size: 1548/2097152 bytes
Highest expansion depth: 11/40
Expensive parser function count: 0/100
Unstrip recursion depth: 0/20
Unstrip post‐expand size: 16534/5000000 bytes
-->
<!--
Transclusion expansion time report (%,ms,calls,template)
100.00%  107.466      1 Template:Article
100.00%  107.466      1 -total
 86.35%   92.794      4 Template:Infobox_section
 29.88%   32.114      9 Template:UserLookup
  4.18%    4.489      1 Template:Review_expired
  1.27%    1.366      1 Template:Get_active_contest
  0.85%    0.908      1 Template:Infobox_end
  0.78%    0.835      1 Template:Infobox_begin
-->
</div></div><div class="printfooter">
Retrieved from "<a dir="ltr" href="https://eyewiki.org/w/index.php?title=Traumatic_Glaucoma&amp;oldid=89296">https://eyewiki.org/w/index.php?title=Traumatic_Glaucoma&amp;oldid=89296</a>"</div>

						<!-- end body text -->
						<!-- data blocks which should go somewhere after the body text, but not before the catlinks block-->
						<div id='mw-data-after-content'>
	<div class="mw-cookiewarning-container"><div class="mw-cookiewarning-text"><span>The Academy uses cookies to analyze performance and provide relevant personalized content to users of our website.</span></div><form method="POST"><div class='oo-ui-layout oo-ui-horizontalLayout'><span aria-disabled='false' class='oo-ui-widget oo-ui-widget-enabled oo-ui-buttonElement oo-ui-buttonElement-framed oo-ui-labelElement oo-ui-flaggedElement-progressive oo-ui-buttonWidget'><a role='button' tabindex='0' aria-disabled='false' href='https://www.aao.org/privacy-policy' rel='nofollow' class='oo-ui-buttonElement-button'><span class='oo-ui-iconElement-icon oo-ui-iconElement-noIcon oo-ui-image-progressive'></span><span class='oo-ui-labelElement-label'>Learn more</span><span class='oo-ui-indicatorElement-indicator oo-ui-indicatorElement-noIndicator oo-ui-image-progressive'></span></a></span><span aria-disabled='false' class='oo-ui-widget oo-ui-widget-enabled oo-ui-inputWidget oo-ui-buttonElement oo-ui-buttonElement-framed oo-ui-labelElement oo-ui-flaggedElement-primary oo-ui-flaggedElement-progressive oo-ui-buttonInputWidget'><button type='submit' tabindex='0' aria-disabled='false' name='disablecookiewarning' value='OK' class='oo-ui-inputWidget-input oo-ui-buttonElement-button'><span class='oo-ui-iconElement-icon oo-ui-iconElement-noIcon oo-ui-image-invert'></span><span class='oo-ui-labelElement-label'>Accept</span><span class='oo-ui-indicatorElement-indicator oo-ui-indicatorElement-noIndicator oo-ui-image-invert'></span></button></span></div></form></div>
</div>

					</div>
					<!-- category links -->
					<div id="catlinks" class="catlinks" data-mw="interface"><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/Special:Categories" title="Special:Categories">Categories</a>: <ul><li><a href="/Category:Articles" title="Category:Articles">Articles</a></li><li><a href="/Category:Glaucoma" title="Category:Glaucoma">Glaucoma</a></li><li><a href="/Category:Ocular_Trauma" title="Category:Ocular Trauma">Ocular Trauma</a></li></ul></div></div>
				</div>
			</div>
		</div>
	</div>
	<div class="mb-2 mt-4 footer container">
		<div class="row">
			<div class="col">
				<!-- navigation bar -->
				<nav class="p-navbar not-collapsible small mb-2" role="navigation" id="mw-navigation-hbpxgz0yra">
					<div class="navbar-nav">
					<!-- toolbox -->
					<div id="t-whatlinkshere" class="nav-item"><a href="/Special:WhatLinksHere/Traumatic_Glaucoma" title="A list of all wiki pages that link here [j]" accesskey="j" class="nav-link t-whatlinkshere">What links here</a></div>
					<div id="t-recentchangeslinked" class="nav-item"><a href="/Special:RecentChangesLinked/Traumatic_Glaucoma" rel="nofollow" title="Recent changes in pages linked from this page [k]" accesskey="k" class="nav-link t-recentchangeslinked">Related changes</a></div>
					<div id="t-specialpages" class="nav-item"><a href="/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q" class="nav-link t-specialpages">Special pages</a></div>
					<div id="t-print" class="nav-item"><a href="javascript:print();" rel="alternate" title="Printable version of this page [p]" accesskey="p" class="nav-link t-print">Printable version</a></div>
					<div id="t-permalink" class="nav-item"><a href="/w/index.php?title=Traumatic_Glaucoma&amp;oldid=89296" title="Permanent link to this revision of the page" class="nav-link t-permalink">Permanent link</a></div>
					<div id="t-info" class="nav-item"><a href="/w/index.php?title=Traumatic_Glaucoma&amp;action=info" title="More information about this page" class="nav-link t-info">Page information</a></div>
					</div>
				</nav>
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- footer links -->
				<div id="footer-info" class="footer-info">
					<!-- info -->
					<div> This page was last edited on February 3, 2023, at 09:07.</div>
					<div>This page has been accessed 35,019 times.</div>
				</div>
				<!-- places -->
				<div id="footer-places" class="footer-places">
					<div><a href="/EyeWiki:Privacy_policy" title="EyeWiki:Privacy policy">Privacy policy</a></div>
					<div><a href="/EyeWiki:About" title="EyeWiki:About">About EyeWiki</a></div>
					<div><a href="/EyeWiki:General_disclaimer" title="EyeWiki:General disclaimer">Disclaimers</a></div>
				</div>
			</div>
			<div class="col">
				<!-- footer icons -->
				<div id="footer-icons" class="justify-content-end footer-icons">
					<!-- poweredby -->
					<div><a href="https://www.mediawiki.org/"><img src="/w/resources/assets/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="/w/resources/assets/poweredby_mediawiki_132x47.png 1.5x, /w/resources/assets/poweredby_mediawiki_176x62.png 2x" width="88" height="31" loading="lazy"/></a></div>
					<div><a href="https://www.semantic-mediawiki.org/wiki/Semantic_MediaWiki"><img src="data:image/png;base64,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" alt="Powered by Semantic MediaWiki" class="smw-footer" width="88" height="31" loading="lazy"/></a></div>
				</div>
			</div>
		</div>
	</div>
<script src="https://www.googletagmanager.com/gtag/js?id=UA-64665049-1" async=""></script><script>
window.dataLayer = window.dataLayer || [];
function gtag(){dataLayer.push(arguments);}
gtag('js', new Date());
gtag('config', 'UA-64665049-1', {});
</script>

<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgPageParseReport":{"smw":{"limitreport-intext-parsertime":0.002},"limitreport":{"cputime":"0.246","walltime":"0.266","ppvisitednodes":{"value":1111,"limit":1000000},"postexpandincludesize":{"value":6640,"limit":2097152},"templateargumentsize":{"value":1548,"limit":2097152},"expansiondepth":{"value":11,"limit":40},"expensivefunctioncount":{"value":0,"limit":100},"unstrip-depth":{"value":0,"limit":20},"unstrip-size":{"value":16534,"limit":5000000},"timingprofile":["100.00%  107.466      1 Template:Article","100.00%  107.466      1 -total"," 86.35%   92.794      4 Template:Infobox_section"," 29.88%   32.114      9 Template:UserLookup","  4.18%    4.489      1 Template:Review_expired","  1.27%    1.366      1 Template:Get_active_contest","  0.85%    0.908      1 Template:Infobox_end","  0.78%    0.835      1 Template:Infobox_begin"]},"cachereport":{"timestamp":"20230306022530","ttl":86400,"transientcontent":false}}});mw.config.set({"wgBackendResponseTime":406});});</script></body>
</html>